Detailed Analysis of the Scope and Claims of United States Patent 11,723,858
Introduction
United States Patent 11,723,858, titled "Topical Antiviral Compositions, Delivery Systems, and Methods of Using the Same," presents a comprehensive innovation in the field of antiviral treatments. This patent, granted to its inventors, outlines novel compositions, delivery systems, and methods for combating viral infections topically.
Patent Overview
Publication Details
- Publication Number: US11723858B2
- Authority: United States Patent and Trademark Office (USPTO)
- Prior Art Date: The patent application was filed on June 14, 2021, indicating the prior art date is relevant to this filing[5].
Scope of the Invention
The patent focuses on the development of topical antiviral compositions and their delivery systems. Here are the key aspects of the invention:
Topical Antiviral Compositions
The compositions described in the patent include various active ingredients and excipients designed to effectively combat viral infections when applied topically. These compositions may include:
- Active Ingredients: Such as nitric oxide, which is known for its antiviral properties.
- Excipients: Including hydroxypropyl cellulose, cellulose, and sugar alcohols, which help in the formulation and stability of the composition[5].
Delivery Systems
The patent also details innovative delivery systems to enhance the efficacy of the antiviral compositions. These systems are designed to ensure the active ingredients are delivered efficiently to the affected area, such as:
- Formulations: Creams, gels, ointments, and other topical formulations that facilitate the application and absorption of the antiviral agents.
- Devices: Specialized delivery devices that could include patches, sprays, or other applicators to ensure precise and controlled release of the antiviral composition[5].
Claims
The patent includes several claims that define the scope of the invention. Here are some of the key claims:
Composition Claims
- Claim 1: A topical antiviral composition comprising an antiviral agent, such as nitric oxide, and a carrier component.
- Claim 2: The composition of claim 1, wherein the carrier component includes hydroxypropyl cellulose and cellulose.
- Claim 3: The composition of claim 1, further comprising a preservative agent to enhance stability[5].
Method Claims
- Claim 4: A method of treating a viral infection, comprising applying the topical antiviral composition to the affected area.
- Claim 5: The method of claim 4, wherein the viral infection is caused by a virus such as the human papillomavirus (HPV)[5].
Delivery System Claims
- Claim 6: A delivery system for the topical antiviral composition, comprising a patch or spray applicator.
- Claim 7: The delivery system of claim 6, wherein the patch is designed for controlled release of the antiviral composition over a specified period[5].
Patent Landscape Analysis
To understand the position of this patent within the broader patent landscape, it is essential to analyze the following aspects:
Technology Category
This patent falls under the category of chemistry and health, specifically within the subcategory of medical technology. According to the USPTO, medical technology is a significant area within the chemistry and health category, accounting for a substantial portion of patents granted in this field[1].
Global and Cross-National Activity
While the patent is granted in the United States, the global patent landscape for antiviral compositions and delivery systems is highly competitive. Countries like the United States, Japan, and EU member states dominate the patent filings in this area. Emerging economies such as South Korea, China, and India are also increasing their patenting activity in these fields[1].
Industry-Level Measures
The patent is likely to be of interest to pharmaceutical and biotechnology companies, as well as research institutions focused on antiviral treatments. The private sector, particularly for-profit companies, receives the majority of patents in the U.S., with a significant share going to high-technology manufacturing and commercial knowledge-intensive services industries[1].
Competitive Analysis
To perform a comprehensive patent landscape analysis, one would need to follow these steps:
- Identify Relevant Patents: Use tools like the USPTO's Patent Public Search, Global Dossier, and international patent databases to identify existing patents in the same technology area[4].
- Analyze Patent Filings: Review the patent filings of key competitors and industry leaders to understand their focus areas and technological advancements[3].
- Evaluate Technology Trends: Analyze the trends in patent filings over time to identify emerging technologies and areas of innovation[1].
- Assess Geographic Distribution: Examine the geographic distribution of patent filings to understand the global competitive landscape[1].
Key Takeaways
- Innovation in Antiviral Treatments: The patent represents a significant innovation in the development of topical antiviral compositions and delivery systems.
- Comprehensive Claims: The patent includes detailed claims covering the composition, methods of use, and delivery systems.
- Competitive Landscape: The patent is part of a highly competitive global landscape dominated by the U.S., Japan, and EU, with emerging economies also playing a significant role.
- Industry Relevance: The patent is crucial for pharmaceutical and biotechnology companies, as well as research institutions focused on antiviral treatments.
FAQs
Q: What is the primary focus of United States Patent 11,723,858?
A: The primary focus is on the development of topical antiviral compositions and their delivery systems.
Q: What are the key ingredients in the antiviral compositions described in the patent?
A: The compositions include active ingredients like nitric oxide and excipients such as hydroxypropyl cellulose and cellulose.
Q: How does the patent contribute to the existing body of knowledge in antiviral treatments?
A: The patent introduces novel compositions and delivery systems that enhance the efficacy of antiviral treatments when applied topically.
Q: Which industries are most likely to be interested in this patent?
A: Pharmaceutical and biotechnology companies, as well as research institutions focused on antiviral treatments.
Q: How can one perform a patent landscape analysis for this technology area?
A: By using tools like the USPTO's Patent Public Search, analyzing patent filings of competitors, evaluating technology trends, and assessing the geographic distribution of patent filings.
Sources
- National Science Foundation. "Chapter 8 - Invention, Knowledge Transfer, and Innovation."
- USA.gov. "U.S. Patent and Trademark Office (USPTO)."
- IP Checkups. "How to perform a patent landscape analysis in 5 key steps."
- USPTO. "Search for patents."
- Google Patents. "US11723858B2 - Topical antiviral compositions, delivery systems, and methods of using the same."
